New Potential Therapeutic Approach for the Treatment of B-Cell Malignancies Using Chlorambucil/Hydroxychloroquine-Loaded Anti-CD20 Nanoparticles

Internalization pathways into cancer cells of gadolinium-based radiosensitizing nanoparticles

(2012) Wael Rima et al.   BIOMATERIALS

ER stress and autophagy: new discoveries in the mechanism of action and drug resistance of the cyclin-dependent kinase inhibitor flavopiridol

(2012) E. Mahoney et al.   BLOOD

Burkitt's lymphoma

(2012) Elizabeth M Molyneux et al.   LANCET

CD38 and chronic lymphocytic leukemia: a decade later

(2011) F. Malavasi et al.   BLOOD

Lysosomal Transmembrane Protein LAPTM4B Promotes Autophagy and Tolerance to Metabolic Stress in Cancer Cells

(2011) Y. Li et al.   CANCER RESEARCH

Principles and Current Strategies for Targeting Autophagy for Cancer Treatment

(2011) R. K. Amaravadi et al.   CLINICAL CANCER RESEARCH

Nanomaterials for cancer therapy and imaging

(2011) Ki Hyun Bae et al.   MOLECULES AND CELLS

Nanoparticle-induced vascular blockade in human prostate cancer

(2010) L. Agemy et al.   BLOOD

The Lysosomotropic Agent, Hydroxychloroquine, Delivered in a Biodegradable Nanoparticle System, Overcomes Drug Resistance of B-Chronic Lymphocytic Leukemia Cells In Vitro

(2010) Eduardo Mansilla et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Dasatinib Plus Nutlin-3 Shows Synergistic Antileukemic Activity in Both p53wild-type and p53mutated B Chronic Lymphocytic Leukemias by Inhibiting the Akt Pathway

(2010) G. Zauli et al.   CLINICAL CANCER RESEARCH

Cyclin-Dependent Kinase Inhibitors as Anticancer Drugs

(2010) Vladimir Krystof et al.   CURRENT DRUG TARGETS

Anti-CD8 conjugated nanoparticles to target mammalian cells expressing CD8

(2010) A. Bicho et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Targeting of drugs and nanoparticles to tumors

(2010) Erkki Ruoslahti et al.   JOURNAL OF CELL BIOLOGY

The molecular background of aggressive B cell lymphomas as a basis for targeted therapy

(2010) Daphne de Jong et al.   JOURNAL OF PATHOLOGY

Interaction of the Retinoblastoma Protein with Orc1 and Its Recruitment to Human Origins of DNA Replication

(2010) Ramiro Mendoza-Maldonado et al.   PLoS One

Hydroxychloroquine, chloroquine, and all-trans retinoic acid regulate growth, survival, and histone acetylation in breast cancer cells

(2009) Rayhana Rahim et al.   ANTI-CANCER DRUGS

Targeted epidermal growth factor receptor nanoparticle bioconjugates for breast cancer therapy

(2009) Sarbari Acharya et al.   BIOMATERIALS

Biodegradable PLGA based nanoparticles for sustained regional lymphatic drug delivery

(2009) Deepa A. Rao et al.   JOURNAL OF PHARMACEUTICAL SCIENCES

Nanoparticles of Biodegradable Polymers for Cancer Treatment

(2008)   BIOMATERIALS

A prospective clinicopathologic study of dose-modified CODOX-M/IVAC in patients with sporadic Burkitt lymphoma defined using cytogenetic and immunophenotypic criteria (MRC/NCRI LY10 trial)

(2008) G. M. Mead et al.   BLOOD

Diffuse large B-cell lymphoma: reduced CD20 expression is associated with an inferior survival

(2008) N. A. Johnson et al.   BLOOD

Polymeric nanoparticles for cancer therapy

(2008) Suphiya Parveen et al.   JOURNAL OF DRUG TARGETING

Micro/nanostructured polymeric systems for biomedical and pharmaceutical applications

(2008) Federica Chiellini et al.   Nanomedicine

Surface-structure-regulated cell-membrane penetration by monolayer-protected nanoparticles

(2008) Ayush Verma et al.   NATURE MATERIALS

Nanoparticle therapeutics: an emerging treatment modality for cancer

(2008) Mark E. Davis et al.   NATURE REVIEWS DRUG DISCOVERY

Ocular Toxicity of Hydroxychloroquine

(2008) Rodney Tehrani et al.   Seminars in Ophthalmology